Assembly Biosciences, Inc. ASMB NASDAQ

Assembly Biosciences, Inc. (ASMB) generated $14.24M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $24K, free cash flow was $14.21M.

Free cash flow margin was 33.5% of revenue. Cash conversion ratio was 0.64x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
• MOAT (50/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (10/100) — Cash conversion ratio was 0.64x suggests some earnings are non-cash items

Overall SharesGrow Score: 59/100 with 4/7 criteria passed.